哈尔滨医科大学附属第二医院Second Affiliated Hospital of Harbin Medical University

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Harbin 哈尔滨市

   已发表研究

   • A Nomogram Integrating Deep Learning and Immunoscore for Predicting Distant Metastasis and Prognosis in Rectal Cancer. Academic radiology, 2026
   • Tumor-immune microenvironment and nutritional status biomarkers predict recurrence after total colectomy for locally advanced colon cancer: development and internal validation of a nomogram. Frontiers in genetics, 2026

   另有 6 项已发表研究

   PubMed 收录了 8 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

2. Breast cancer

   Harbin 哈尔滨市

   已发表研究

   • The YAP-TEAD4 inhibitor M511-0965 suppresses triple-negative breast cancer progression by downregulating TGFB2. Translational oncology, 2026
   • Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study. Cancers, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

3. Lung cancer

   Harbin 哈尔滨市

   已发表研究

   • Integration of habitat radiomics and 2.5D deep features from (18)F-FDG PET/CT for noninvasive prediction of PD-L1 TPS ≥ 50% in non-small cell lung cancer. European journal of radiology, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

4. Liver cancer

   Harbin 哈尔滨市

   已发表研究

   • Retraction notice to “RNA-seq shows angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages” [Int. J. Biol. Macromol. 287 (2025) 138523]. International journal of biological macromolecules, 2026
   • PTPN14 functions as an oncogenic promoter in colon adenocarcinoma and liver hepatocellular carcinoma via Notch Signaling. Cellular signalling, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

5. Stomach cancer

   Harbin 哈尔滨市

   已发表研究

   • CMTM3 links inflammation-related transcriptional dysregulation to immune and therapeutic stratification in gastric cancer. Translational oncology, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

6. Prostate cancer

   Harbin 哈尔滨市

   已发表研究

   • Transcription Factor 21 Inhibits Prostate Cancer Progression via Transcriptional Repression of PSAT1. The Tohoku journal of experimental medicine, 2026
   • AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers. Journal of magnetic resonance imaging : JMRI, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

7. Thyroid cancer

   Harbin 哈尔滨市

   已发表研究

   • The role of plectin as a druggable target in papillary thyroid carcinoma: therapeutic potential of troglitazone. Frontiers in immunology, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Otorhinolaryngology 获提名。

8. Nasopharyngeal carcinoma

   Harbin 哈尔滨市

   复旦专科声誉排行榜 2023

   • Otorhinolaryngology 获提名 https://www.fdygs.com/news2023-1.aspx